Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

32.01
-1.6100-4.79%
Post-market: 31.81-0.1961-0.61%19:46 EDT
Volume:1.59M
Turnover:52.09M
Market Cap:3.86B
PE:-10.57
High:34.39
Open:34.12
Low:31.98
Close:33.62
Loading ...
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 03, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 15, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]